1. Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry
- Author
-
María E. Ramos-Araque, James E. Siegler, Marc Ribo, Manuel Requena, Cristina López, Mercedes de Lera, Juan F. Arenillas, Isabel Hernández Pérez, Beatriz Gómez-Vicente, Blanca Talavera, Pere Cardona Portela, Ana Nuñez Guillen, Xabier Urra, Laura Llull, Arturo Renú, Thanh N. Nguyen, Dinesh Jillella, Fadi Nahab, Raul Nogueira, Diogo Haussen, Ryna Then, Jesse M. Thon, Luis Rodríguez Esparragoza, Maria Hernández-Pérez, Alejandro Bustamante, Ossama Yassin Mansour, Mohammed Megahed, Tamer Hassan, David S. Liebeskind, Ameer Hassan, Saif Bushnaq, Mohamed Osman, Alejandro Rodriguez Vazquez, and SVIN Multinational Registry and Task Force
- Subjects
Stroke ,COVID-19 ,Coronavirus ,Cryptogenic ,Mortality ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background and purpose Coronavirus disease 2019 (COVID-19) is associated with a small but clinically significant risk of stroke, the cause of which is frequently cryptogenic. In a large multinational cohort of consecutive COVID-19 patients with stroke, we evaluated clinical predictors of cryptogenic stroke, short-term functional outcomes and in-hospital mortality among patients according to stroke etiology. Methods We explored clinical characteristics and short-term outcomes of consecutively evaluated patients 18 years of age or older with acute ischemic stroke (AIS) and laboratory-confirmed COVID-19 from 31 hospitals in 4 countries (3/1/20–6/16/20). Results Of the 14.483 laboratory-confirmed patients with COVID-19, 156 (1.1%) were diagnosed with AIS. Sixty-one (39.4%) were female, 84 (67.2%) white, and 88 (61.5%) were between 60 and 79 years of age. The most frequently reported etiology of AIS was cryptogenic (55/129, 42.6%), which was associated with significantly higher white blood cell count, c-reactive protein, and D-dimer levels than non-cryptogenic AIS patients (p
- Published
- 2021
- Full Text
- View/download PDF